Literature DB >> 26088574

High-density lipoproteins reduce endothelial-to-mesenchymal transition.

Frank Spillmann1, Kapka Miteva1, Burkert Pieske1, Carsten Tschöpe1, Sophie Van Linthout2.   

Abstract

OBJECTIVE: Endothelial-to-mesenchymal transition is an inflammation-induced process by which endothelial cells can transdifferentiate into fibroblasts. Based on the endothelial-protective and antifibrotic effects of high-density lipoproteins (HDL), we aimed to investigate whether HDL can reduce endothelial-to-mesenchymal transition. APPROACH AND
RESULTS: Therefore, human aortic endothelial cells were stimulated with the profibrotic factor transforming growth factor (TGF)-β1 in the presence or absence of HDL. Their impact on the transition of endothelial cells to mesenchymal-like cells was analyzed. Phase contrast microscopy demonstrated that HDL abrogated the TGF-β1-induced spindle-shape morphology in human aortic endothelial cells. Furthermore, HDL decreased the TGF-β1-mediated induction of α-smooth muscle actin expression and concomitant loss in endothelial cadherin expression, as shown by immunofluorescence staining and flow cytometry. In addition, HDL decreased the TGF-β1-induced collagen deposition in human aortic endothelial cells involving the scavenger receptor class B, type 1 and downstream phosphatidyl inositol-3-kinase following the findings that the HDL-mediated reduction was abrogated by scavenger receptor class B, type 1 siRNA knockdown and phosphatidyl inositol-3-kinase inhibition, respectively. The HDL-mediated reduction in endothelial-to-mesenchymal transition was associated with an induction of the inhibitory Smad, Smad 7.
CONCLUSIONS: We provide the first in vitro evidence that the endothelial-protective and antifibrotic effects of HDL include the reduction in endothelial-to-mesenchymal transition.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  HDL; aortic endothelial cells; endothelial-to-mesenchymal transition; fibrosis; transforming growth factor

Mesh:

Substances:

Year:  2015        PMID: 26088574     DOI: 10.1161/ATVBAHA.115.305887

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

Review 1.  Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.

Authors:  Carsten Tschöpe; Sophie Van Linthout; Behrouz Kherad
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 2.  Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Jason C Kovacic; Stefanie Dimmeler; Richard P Harvey; Toren Finkel; Elena Aikawa; Guido Krenning; Andrew H Baker
Journal:  J Am Coll Cardiol       Date:  2019-01-22       Impact factor: 24.094

Review 3.  HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.

Authors:  C R Sirtori; M Ruscica; L Calabresi; G Chiesa; R Giovannoni; J J Badimon
Journal:  Ann Med       Date:  2019 Nov - Dec       Impact factor: 4.709

Review 4.  Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases.

Authors:  Xuexin Lu; Jiannan Gong; Phyllis A Dennery; Hongwei Yao
Journal:  Biochem Pharmacol       Date:  2019-06-26       Impact factor: 5.858

Review 5.  Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.

Authors:  Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Physiol Rev       Date:  2019-04-01       Impact factor: 37.312

6.  Successful treatment of established heart failure in mice with recombinant HDL (Milano).

Authors:  Joseph Pierre Aboumsallem; Mudit Mishra; Ruhul Amin; Ilayaraja Muthuramu; Herman Kempen; Bart De Geest
Journal:  Br J Pharmacol       Date:  2018-09-19       Impact factor: 8.739

7.  Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.

Authors:  Kapka Miteva; Sophie Van Linthout; Kathleen Pappritz; Irene Müller; Frank Spillmann; Marion Haag; Harald Stachelscheid; Jochen Ringe; Michael Sittinger; Carsten Tschöpe
Journal:  Stem Cells Transl Med       Date:  2016-07-26       Impact factor: 6.940

Review 8.  Fibroblast growth factor-transforming growth factor beta dialogues, endothelial cell to mesenchymal transition, and atherosclerosis.

Authors:  Pei-Yu Chen; Michael Simons
Journal:  Curr Opin Lipidol       Date:  2018-10       Impact factor: 4.776

Review 9.  High-density lipoprotein-mediated cardioprotection in heart failure.

Authors:  Ampadu O Jackson; Jun Meng; Huifang Tang; Kai Yin
Journal:  Heart Fail Rev       Date:  2021-07       Impact factor: 4.214

10.  Intracellular Ca2+ Dysregulation in Coronary Smooth Muscle Is Similar in Coronary Disease of Humans and Ossabaw Miniature Swine.

Authors:  Jill K Badin; Caleb Eggenberger; Stacey Dineen Rodenbeck; Zubair A Hashmi; I-Wen Wang; Jose P Garcia; Mouhamad Alloosh; Michael Sturek
Journal:  J Cardiovasc Transl Res       Date:  2021-07-20       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.